image
Post On April 1st, 2017

Launching of Antihypertensive & Cardiac Products

Nuvista Pharma Limited has strengthened its position in the Pharma Market with its new “Antihypertensive & Cardiac Portfolio” and the introduction of a number of promising molecules within its “Antihypertensive & Cardiac Portfolio”

Products already launched:-

1.      Cardifort 5 (Amlodipine 5 mg)

2.      Cardifort Plus 25 ( Amlodipine 5 mg +Atenolol 25 mg)

3.      Cardifort Plus 50 ( Amlodipine 5 mg +Atenolol 50 mg)

4.      Nusartan 25 (Losartan Potassium 25 mg)

5.      Nusartan 50 (Losartan Potassium 50 mg)

6.      Atrovast ( Atorvastatin 10 mg)

7.      Atrovast 20 ( Atorvastatin 20 mg)